Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 5, 2022 · 10-Q · 35 days after period end · 0001069530-22-000023
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$17.53M | -$3.53M | -$1.15M | -$1.36M |
| EPS Diluted | -$0.44 | -$0.09 | -$0.05 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 5, 2022 · 35 d after period end
